222 related articles for article (PubMed ID: 6124264)
1. Labetalol in essential hypertension.
Breckenridge A; Orme M; Serlin MJ; Maciver M
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
[TBL] [Abstract][Full Text] [Related]
2. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
3. Comparison of labetalol with other anti-hypertensive drugs.
Prichard BN; Richards DA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
[TBL] [Abstract][Full Text] [Related]
4. Experience with labetalol in hypertension.
Bolli P; Waal-Manning J; Wood AJ; Simpson FO
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
Hansson L; Hänel B
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
[TBL] [Abstract][Full Text] [Related]
6. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Thompson FD; Joekes AM; Hussein MM
Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
[TBL] [Abstract][Full Text] [Related]
7. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
8. Step II treatment with labetalol for essential hypertension.
Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
[TBL] [Abstract][Full Text] [Related]
9. Labetalol in long-term treatment of hypertension.
Prichard BN; Boakes AJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
11. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
12. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
[TBL] [Abstract][Full Text] [Related]
13. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
Michelson EL; Frishman WH
Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
16. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
[TBL] [Abstract][Full Text] [Related]
17. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
Rossi A; Ziacchi V; Lomanto B
Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.
Kristensen BO; la Cour Petersen E
Postgrad Med J; 1980; 56 Suppl 2():57-9. PubMed ID: 7433344
[No Abstract] [Full Text] [Related]
19. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
20. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
Stern N; Teicher A; Rosenthal T
Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]